Synthesis and in Vitro Biological Evaluation of Carbonyl Group-Containing Analogues for σ1 Receptors

被引:15
作者
Wang, Wei [1 ]
Cui, Jinquan [1 ]
Lu, Xiaoxia [1 ]
Padakanti, Prashanth K. [1 ]
Xu, Jinbin [1 ]
Parsons, Stanley M. [2 ,3 ]
Luedtke, Robert R. [4 ]
Rath, Nigam P. [5 ,6 ]
Tu, Zhude [1 ]
机构
[1] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA
[2] Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA
[3] Univ Calif Santa Barbara, Grad Program Biochem & Mol Biol, Santa Barbara, CA 93106 USA
[4] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA
[5] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA
[6] Univ Missouri, Ctr Neurosci, St Louis, MO 63121 USA
基金
美国国家卫生研究院;
关键词
POSITRON-EMISSION-TOMOGRAPHY; STRUCTURE-AFFINITY; VIVO EVALUATION; BINDING-SITE; LIGANDS; CELLS; RADIOTRACER; EXPRESSION; CANCER; PHARMACOLOGY;
D O I
10.1021/jm200203f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To identify the ligands for sigma(1) receptors that are potent and selective, analogues of prezamicol and trozamicol scaffolds of carbonyl-containing vesicular acetylcholine transporter (VAChT) inhibitors were explored. Of the 23 analogues synthesized and tested, 5 displayed very high affinity for sigma(1)(K-i = 0.48-4.05 nM) and high selectivity for sigma(1) relative to sigma(2) receptors (sigma(1)/sigma(2) selectivity of >749-fold). Four of the five compounds (14a, 14b, 14c, and 14e) showed very low affinity for VAChT (K-i > 290 nM), and the fifth compound (14g) showed moderate affinity for VAChT (K-i = 44.2 nM). The compound [1'-(4-fluorobenzy1)-3'-hydroxy[1,4']bipiperidinyl-4-yl]-(4-fluorophenyl)methanone (14a) displayed very high affinity and selectivity for sigma(1) receptor (K-i = 0.48 nM, sigma(1)/sigma(2) > 3600). All four of these most promising compounds (14a, 14b, 14c, and 14e) can be radiosynthesized with fluorine-18 or carbon-11, which will allow further evaluation of their properties as PET probes for imaging sigma(1) receptor in vivo.
引用
收藏
页码:5362 / 5372
页数:11
相关论文
共 51 条
  • [41] 4-IBP, a σ1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs
    Megalizzi, Veronique
    Mathieu, Veronique
    Mijatovic, Tatjana
    Gailly, Philippe
    Debeir, Olivier
    De Neve, Nancy
    Van Damme, Marc
    Bontempi, Gianluca
    Haibe-Kains, Benjamin
    Decaestecker, Christine
    Kondo, Yasuko
    Kiss, Robert
    Lefranc, Florence
    [J]. NEOPLASIA, 2007, 9 (05): : 358 - 369
  • [42] Screening of anti-glioma effects induced by sigma-1 receptor ligands: Potential new use for old anti-psychiatric medicines
    Megalizzi, Veronique
    Decaestecker, Christine
    Debeir, Olivier
    Spiegl-Kreinecker, Sabine
    Berger, Walter
    Lefranc, Florence
    Kast, Richard E.
    Kiss, Robert
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (16) : 2893 - 2905
  • [43] Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy
    Ogawa, Kazuma
    Shiba, Kazuhiro
    Akhter, Nasima
    Yoshimoto, Mitsuyoshi
    Washiyama, Kohshin
    Kinuya, Seigo
    Kawai, Keiichi
    Mori, Hirofumi
    [J]. CANCER SCIENCE, 2009, 100 (11) : 2188 - 2192
  • [44] A PROPOSAL FOR THE CLASSIFICATION OF SIGMA BINDING-SITES
    QUIRION, R
    BOWEN, WD
    ITZHAK, Y
    JUNIEN, JL
    MUSACCHIO, JM
    ROTHMAN, RB
    SU, TP
    TAM, SW
    TAYLOR, DP
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (03) : 85 - 86
  • [45] Small molecule antagonists of the σ-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo
    Spruce, BA
    Campbell, LA
    McTavish, N
    Cooper, MA
    Appleyard, MVL
    O'Neill, M
    Howie, J
    Samson, J
    Watt, S
    Murray, K
    McLean, D
    Leslie, NR
    Safrany, ST
    Ferguson, MJ
    Peters, JA
    Prescott, AR
    Box, G
    Hayes, A
    Nutley, B
    Raynaud, F
    Downes, CP
    Lambert, JJ
    Thompson, AM
    Eccles, S
    [J]. CANCER RESEARCH, 2004, 64 (14) : 4875 - 4886
  • [46] Synthesis and Pharmacological Evaluation of Fluorine-Containing D3 Dopamine Receptor Ligands
    Tu, Zhude
    Li, Shihong
    Cui, Jinquan
    Xu, Jinbin
    Taylor, Michelle
    Ho, David
    Luedtke, Robert R.
    Mach, Robert H.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1555 - 1564
  • [47] VILNER BJ, 1995, CANCER RES, V55, P408
  • [48] Clinical trials with sigma ligands
    Volz, HP
    Stoll, KD
    [J]. PHARMACOPSYCHIATRY, 2004, 37 : S214 - S220
  • [49] In vivo evaluation in rats of [18F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptors
    Waterhouse, RN
    Chang, RC
    Zhao, J
    Carambot, PE
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (02) : 211 - 215
  • [50] Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [18F]FPS
    Waterhouse, RN
    Stabin, MG
    Page, JG
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2003, 30 (05) : 555 - 563